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An Interprofessional Approach to Train Medical Students & Respiratory Therapy Students
in Basic Principles of Mechanical Ventilation
Mary Jo S. Farmer, MD, PhD Baystate Medical Center Springfield, MA
PROFESSIONAL EXPECTATION

RESULTS (CONT’D
FOCUS GOUP1 (CONT’D)
Valuable to train alongside students of other disciplines in the classroom (Y/N)
Care of the mechanically ill ventilated critically patient in the Medical ICU is Lectures beneficial - more hands on
• Group 1
More time with patients
accomplished by a team of health care professionals
• Pre-test: 1 MS “depends”; others “yes”
Optimum communication between the physician and respiratory therapist is Less didactic and more group problem solving
• Post-test: 2 MS “no”
Vocabulary (PEEP, DKA)
essential in providing mechanical ventilator support
• Group 2
Not enough time to master material
A professional working relationship includes mutual respect and
• Pre-test: all “yes”
understanding of the roles and responsibilities of each discipline of the health Limited opportunity to know other students
• Post-test: 1 MS “no”; others “yes”
Provide snacks
care team
Valuable to train alongside students of other disciplines in clinical setting
GOALS
(Y/N)
FOCUS GROUP 2
Promote knowledge regarding mechanical ventilation including ABG
• Group 1
Working with different professionals very valuable
analysis, modes of mechanical ventilation, ventilator settings,
• Pre-test: 1 MS “depends”; others “yes”
Learn roles
basic waveform analysis.
• Post-test: 1 MS “no”
Work alongside other students to take better care of patients
Providing opportunity for interprofessional interaction at the student
• Group 2
level will ease transition to health care team model at the professional level ABGs, specifically how to use ventilator to turn ABG around
• Pre-test: all “yes”
Approach a patient on a ventilator
Learning to feel confident when stating my opinion about what would be best • Post-test: all “yes”
IMPLEMENTATION
Topic least knowledgeable
for patient and why
• 2 groups (group 1 7MD/7RT; group 2 8MD/7RT)
Does what we learn in medical school correlate with what other professionals • Group 1
• Common components:
• Pre-test: 10 waveform analysis; 2 weaning
are taught in regards to approaching a patient with a respiratory problem
• 4 week sessions – 2.5 hours
• Post-test: 8 weaning; 5 waveform analysis
What does the MD need to know to manage ICU patients
• Pre-test (9 core material; 6 opinion; 2 open-ended)
• Group 2
When to call RT and involve in decision making process
• Post-test
• Pre-test: 10 waveform analysis; 4 weaning
Lots of clinical examples and clinical problems
• Focus group
• Post-test: 7 waveform analysis; 5 weaning
How to set the ventilator and manipulate settings
• Differences:
Topic most knowledgeable
Simulation laboratory
• Group 1 (7MD/7RT)
• Group 1
Reading material – not being tested
• Traditional lectures on ABG analysis
• Pre-test: 14 arterial blood gas analysis
• modes of mechanical ventilation and waveform analysis including
• Post-test: 13 arterial blood gas analysis
RESULTS
problem solving
• Group 2
Core questions (9)
• small group MICU bedside
• Group 1 (7MD/7RT)
• Pre-test: 14 ABG analysis; 1 initiating MV
• Group 2 (8 MD/7RT)
• Pre-test
• Post-test: 11 ABG analysis; 3 initiating MV
• Independent reading
• Respiratory (11) + Medical (20) = 31
• Small intentionally mixed groups
LESSONS LEARNED
• Post-test
• Independent case problem solving
• Respiratory (35) + Medical (27) = 62
• Chemistry within group is crucial
• Bedside ICU
• Group 2 (8MD/7RT)
• Expectations
FOCUS GROUP 1
• Pre-test
• Seating
Exposure to attending MD valuable
• Respiratory (16) + Medical (23) = 41
• Introduction and ice breaker
MICU great experience
• Post-test
• Comfort level – timing in clinical year “clinical savvy”
Why 3rd year
• Respiratory (30) + Medical (44) = 74
• One of me
Shelf exam
• Next step – nurses, simulation, on-line
Intimidation
Special thanks:
Assumed difference in knowledge level
Tufts University School of Medicine Innovations in Education Grant
MS versus RT - proficient in waveforms

Dr. Michael Picchioni, TUSM IM Core Clerkship Director, Baystate Medical Center; Ester Perrelli, Director of Clinical Rotations,
Springfield Technical Community College; Reva Kleppel, Academic Affairs, Baystate Medical Center

An Observational Study on the Management Practices of Postoperative New
Onset Atrial Fibrillation in Non-cardiothoracic Surgeries at a Tertiary Care
Center
Kanval Shah, MD; Anis John Kadado, MD; Mihaela Tiru, MD; Vida Rastegar, MPH;
Kirti K Joshi, MD; Peter Lindenauer, MD, MSc; Tara Lagu, MD; Mihaela S Stefan, MD, PhD
y

BACKGROUND
• Postoperative atrial fibrillation (POAF) is the most common
perioperative arrhythmia and it’s incidence in noncardiothoracic surgery varies from 0.4% to 26%.
• POAF was considered to be self-limited and to have a favorable
prognosis, but recent data has linked it to increased in-hospital
mortality, length of stay, hospital costs and risk of stroke.

METHODS
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• Retrospective, single-center cohort study of adult patients who
underwent non-cardiothoracic surgery and developed new
onset POAF.

RESULTS

• There are no specific guidelines for the management of these
patients.
• Objective: To characterize in-hospital diagnostic testing,
medical treatments and discharge recommendations in order to
inform future practice guidelines and need for further research.

Figure 3- Graph showing consults obtained based on type of
surgery

Figure 2- Flowchart depicting management strategies
• During the 6 years of the study ,99 patients were identified with
new onset POAF
• Patient characteristics: The median age was 75 years and 57.6%
were male, with hypertension (66.7%) and diabetes mellitus
(30.3%) being the most common comorbidities.
• 28.3% of the patients underwent colorectal surgery, 14.1%
orthopedic surgeries, 14.1% vascular surgeries and 29.0% had
trauma, hepatobiliary, genitourinary and neurosurgery
procedures.
• Consults were called in 74% of the cases
• Short term outcomes: Median length of hospitalization was 9
days (IQR: 6-18). 2% had a stroke during hospitalization and 16%
Figure 1-Flow chart representing study screening, selection process
died.
and outcomes

• Anticoagulation was prescribed in 25% of the patients during
hospitalization and in half of those discharged in AF. The
CHADS2-VASc score and the HAS-BLED score did not correlate
with the prescription of anticoagulation on discharge.
• Long term outcomes: 30% were readmitted and half of them
were in AF at the time of admission

Conclusions
• There was significant practice variation between providers in
the choice of strategies for short and long-term management
of patients with POAF.
• Most patients were asymptomatic but their outcomes were
not different from the symptomatic patients raising questions
about appropriate cardiac monitoring of surgical patients.
• Risk scores to identify patients at high risk for POAF are
urgently needed.
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HIV Clinicians’ Intention to Prescribe Buprenorphine and Naloxone:
Baseline Results from the PTSL study
Eric Romo BA; Donna Wilson MS; Alexander Y. Walley MD, MSc; Josiah D. Rich MD, MPH; Traci C. Green PhD, MSc; Susan E. Ramsey PhD;
Jeffrey Bratberg PharmD; Michelle McKenzie MPH; Randall Hoskinson, Jr BS; Haley Guhn-Knight BA; & Peter D. Friedmann MD, MPH
University of Massachusetts Medical School – Baystate

Background
• The use of opioids is common among persons living with HIV
(PLWH), resulting in high rates of opioid overdose among PLWH.
• Office-based buprenorphine treatment has been shown to reduce
overdose mortality, and naloxone is an effective opioid reversal
agent.
• Despite this, HIV clinicians have been reluctant to adopt officebased buprenorphine treatment and naloxone prescribing.

Objective
• To identify factors associated with HIV prescribers’ intention
to prescribe buprenorphine and naloxone.

Methods
Data Source
• These are baseline data from the Prescribe to Save Lives
(PTSL) study.
Study Sample
• 119 prescribers (physicians, advanced practitioners) from
23 HIV outpatient practices across 18 states.
• Inclusion criteria for HIV practices were that they: (1)
receive Ryan White funding; (2) treat adults with HIV; (3)
have 3 or more prescribing clinicians; (4) have an EMR with
an electronic medication list; (5) are located in a state in the
top half nationally for opioid overdose deaths; (6) are
located in a state that has 500 or more PLWH.
Outcome Measure
• Prescribers reported intention to prescribe buprenorphine
and naloxone: “How likely are you to prescribe
[medication]?”
• 5-point Likert scale, from (1) Not at all likely to (5) Very
much so likely.
• Intention to prescribe treated as a continuous variable
Potential Correlates
• Prescribers’ demographics, substance use assessment
practices, addiction training, attitudes and knowledge
towards buprenorphine and naloxone, and the substance
use characteristics of their patient panel
• These factors were assessed in the baseline survey
Statistical Analysis
• Mixed-effects linear regression models to identify factors
associated with intention to prescribe buprenorphine and
naloxone.
• Account for the nested structure of the data (prescribers
in practices)

Contact Information:
Eric Romo | Eric.Romo@baystatehealth.org

Conclusion

Results
Table 1. Characteristics of HIV Prescribers (N=119)
Characteristics
Demographics
Female
Age (years)
White (vs. non-White)
Profession
Physician
Nurse Practitioner
Physician Assistant
Intention to Prescribe
Buprenorphine (1 to 5 scale)
Naloxone (1 to 5 scale)

• HIV prescribers’ intention to prescribe buprenorphine and naloxone
was associated with previous training and knowledge of these
medications and greater self-efficacy.
• Training and mentoring interventions, like that underway in the
PTSL study, have the potential to increase uptake of office-based
buprenorphine treatment and naloxone prescribing among HIV
clinicians

% or mean (sd)
72%
43 (10)
62%
49%
42%
8%

Overview of the Prescribe To Save Lives study

2.9 (1.5)
3.3 (1.4)

Table 2. Mixed-Effects Linear Models: Factors Associated with Intention
to Prescribe Buprenorphine and Naloxone
Variable
Prescriber Demographics
Female
Age (per 10 years)
Non-White Race (vs. White)
Assessment of Patients
Assess illicit use of opioids
Inform patients about sources for sterile
syringes
Patient Substance Use
Had a patient who overdosed on opioids
Don't Know
Yes
No (reference)
Prior Training
Completed a buprenorphine course (Yes vs.
No)
Amount of naloxone training
Attitudes and Beliefs
Buprenorphine maintenance blocks effects of
opioids
Buprenorphine reduces risk of dying
Naloxone reduces risk of dying
Overdose must be handled by professionals
Confidence in Prescribing (1-100 scale)
Confidence in prescribing buprenorphine (per
10 points)
Confidence in prescribing naloxone (per 10
points)

Buprenorphine
Beta Std. Error p-value

Naloxone
Std. Error p-value

Beta

-0.21
-0.17
0.09

0.21
0.10
0.20

0.33
0.09
0.66

-0.35
-0.33
-0.41

0.22
0.10
0.21

0.14
0.002
0.07

0.15

0.09

0.12

-0.10

0.10

0.32

-0.06

0.07

0.35

0.09

0.08

0.27

-0.82
-0.57
--

0.32
0.31
--

0.02
0.08
--

-0.86
-0.58
--

0.34
0.34
--

0.02
0.11
--

0.99
--

0.26
--

0.0003
--

-0.08
0.19

0.23
0.09

0.72
0.03

0.35
0.21
---

0.12
0.15
---

0.004
0.15
---

--0.07
-0.08

--0.15
0.09

--0.64
0.39

0.14

0.03

< 0.001

--

--

--

--

--

--

0.14

0.04

0.0006

• Prescribers expressed moderate intention to prescribe
buprenorphine (mean score= 2.9, SD=1.5) and naloxone (mean
score=3.3, SD=1.4).
• Positive correlates for bup included: having completed a bup
course (b=0.99, p=0.0003), agreeing that bup blocks the effects
of opioids (b=0.35, p=0.004), and greater confidence in
prescribing bup (b=0.14, p < 0.0001)
• Negative correlates for bup:: Report they did not know whether
they had a patient who overdosed on opioids (vs. “No”) (b=-0.82,
p=0.02)
• Positive correlates for naloxone included: greater amount of
naloxone training (b=0.19, p=0.03) and greater confidence in
prescribing naloxone (b=0.14, p=0.0006)
• Negative correlates for naloxone: Age (per 10 years) (b=-0.33,
p=0.002) and not knowing whether they had a patient who
overdosed on opioids (b=-0.86, p=0.02)

PTSL Overview
• PTSL is an implementation intervention trial. Using a stepped
wedge design, the intervention will test the implementation of
evidence-based training, mentoring, technical support, and
academic detailing to encourage HIV clinicians to adopt naloxone
prescribing and office-based opioid treatment with buprenorphine.
• PTSL leverages the value of ”saving lives” among HIV clinicians in
a process to increase their motivation to deliver effective
medications for opioid dependence.
• Beginning with naloxone prescribing, the PTSL study utilizes
academic detailing with motivational interviewing (MI) to encourage
HIV clinicians to accept a larger role in treating the primary disease
(opioid addiction) with office-based buprenorphine.
Implementation Intervention
• Implementation is being rolled out sequentially among HIV
practices in three 6-month phases
• The intervention includes (1) a 1.5-hour, onsite peer-to-peer
training with continuing medical education credits provided that
focuses on saving lives through naloxone prescribing and
introduces the idea that office-based medication is available to
treat the primary disease (opioid addiction) in their office; (2)
expert mentoring and technical support for the physicians and
practice; (3) academic detailing by a clinician trained in MI at 1, 3,
and 5 months after the initial training; and (4) pharmacist peer-topeer outreach to local pharmacies to ensure that the medications
are available.
Outcomes
• Primary outcomes: (1) Feasibility, acceptability, readiness and
intent to prescribe naloxone and buprenorphine; (2) number of
clinicians prescribing naloxone and Bup/Nx (i.e. uptake); (3)
number of patients prescribed naloxone or Bup/Nx (i.e.
penetration).
• Secondary outcomes: (1) themes related to implementation
facilitators and barriers in qualitative interviews; (2) the rate of
physician statements that favor change in prescribing behavior in
the audiotaped detailing sessions (e.g. change talk)

Funding: National Institute on Drug Abuse (R01DA038082)

Saved by the BAL: A Case of Eosinophilic Pneumonia after
Methyl-Naltrexone Injection
Anthony Esposito DO, Benison Lau MD
UMass Medical School - Baystate Medical Center, Springfield, MA

Introduction

Discussion (continued)

Eosinophilic pneumonia (EP) can be an adverse effect of
many drugs, including methly-naltrexone. Methylnaltrexone injection has become increasingly popular,
but its use does not come without risks.

• Methyl-naltrexone is increasingly utilized as an
effective treatment for alcohol dependence disorder.
Its possible association with EP was initially noted in
a large randomized control trial published in JAMA by
Garbutt et al.

Case Summary
A 44-year-old male with history of alcohol use disorder
was brought to the emergency department (ED) by
ambulance in acute respiratory failure. He received his
monthly naltrexone injection three days prior. The
following day, he started having lip swelling, swollen
ankles, severe headache, rash, and two days later, had
dyspnea. Upon arrival to the ED, he was given two doses
of IM epinephrine, as well as methylprednisolone 125 mg
IV, and he required BiPAP, after what was thought to be
an anaphylactic reaction to naltrexone.

• Imaging findings typically include bilateral reticular
ground-glass opacities that expand as the disease
progresses

Conclusion
Image 1: CTA imaging of chest revealed ground-glass opacities bilaterally more
pronounced in the periphery

Discussion

Chest x-ray revealed stable bilateral lower lobe
opacities. CBC demonstrated increased absolute levels
of eosinophils (700k/mm3), anaphylaxis was ruled out
with tryptase level of 2.8 (normal <11.5)

• Acute eosinophic pneumonia is characterized by
acute onset febrile illness, hypoxemia, diffuse bilateral
infiltrates on imaging, and pulmonary eosinophilia
with more than 25% eosinophils in BAL.

CTA of chest demonstrated no evidence of pulmonary
embolism, but did reveal diffuse ground glass opacities
consistent with acute infiltrates.

• EP is characterized by symptoms lasting less than 1
month and usually less than 1 week. EP will respond
rapidly to steroid therapy but early recognition
remains important to choose appropriate therapy
given mimics such as infection.

Bronchoscopy with bronchoalveolar lavage (BAL) was
performed and fluid from the BAL revealed 76 and 37
white blood cells in the right and left fluid samples with
eosinophils making up 50% and 53% of WBC
respectively and fluid was negative for malignant cells.
Eosinophilic pneumonia diagnosis was established and
steroids were initiated with improvement.

• Several medications have historically been shown to
cause EP, in one review of the literature the most
commonly cited drugs include antibiotics, such as
daptomycin, minocycline and nitrofuration, or antiinflammatories, such as mesalamine and
sulfasalazine.

This case demonstrates a likely outcome of eosinophilic
pneumonia in a patient receiving methyl-naltrexone
injections for alcohol use disorder. It is important to
recognize naltrexone as a possible etiology for
eosinophilic pneumonia due to its increasing use,
likelihood of repeat exposure, and if missed with
potential for subsequent harm.

References
Carmi Bartal, MD, MHA,∗ Iftach Sagy, MD, and Leonid Barski, MD. Medicine
(Baltimore). 2018 Jan; 97(4): e9688. Published online 2018 Jan 26. Druginduced eosinophilic pneumonia: A review of 196 case reports
Kim H, Ali M, Buch K. Eosinophilic Pneumonia Induced by Injectable
Naltrexone. Am J Respir Crit Care Med. 2014;189:A2283
Garbutt JC, Kranzler HR, O'Malley SS, Gastfriend DR, Pettinati HM, Silverman
BL, Loewy JW, Ehrich EW; Vivitrex Study Group. Efficacy and tolerability of
long-acting injectable naltrexone for alcohol dependence: a randomized
controlled trial. JAMA. 2005 Apr 6;293(13):1617-25
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THE USE OF COGNITIVE SCREENING AS A PREDICTOR OF
HOSPITALIZATION AND POST-HOSPITALIZATION OUTCOMES
ALI SHAMI,MD; MAURA BRENNAN,MD; PETER ST. MARIE; MIHAELA S STEFAN, MD, PHD

BACKGROUND
• Prior studies suggest that patients with cognitive impairment
(CI) are at risk for worse post-hospitalization outcomes
including hospital readmission and mortality.
• The Mini-Cog test provides a quick bedside screening tool for
cognitive impairment taking only a few minutes to administer.
• Our aim was to determine whether CI as screened for by the
Mini-Cog test early during hospitalization was associated with
hospital readmission, length of stay and mortality.

MINI-COG TEST

RESULTS
• Median age: 80 years (IQR 74-86).
• Gender: 58% female.
• 35% screened positive for CI.
Those screening positive were (p<0.001 for all):
• Older (median age 83 vs 78)
• Had more prior hospitalizations
• Less likely to be admitted from home
• Of lower functional independence and self-reported
performance scores.
• More likely to be discharged to a post-acute care facility
(54% vs 39%).
Table 1. Unadjusted Outcomes Based on Cognitive Screening Result.

METHODS
• Prospective cohort study: 668 patients ≥ 65 years of age
admitted to Baystate Medical Center over a two-year period.
• Both medical and surgical inpatients were screened for CI
with the Mini-Cog test within 24 hours of admission.
• Demographic information, comorbidities, diagnoses, length of
stay and readmission events were all collected.
• One-year mortality data was obtained from the National
Death Index.
• We performed multivariable regression adjusting for
confounders to determine association between CI and our
outcomes.

[1]

Cognitive Screening
Total
N
668
30 Day Readmission 101 (15.1)
(%)
60 Day Readmission 167 (25.0)
(%)
90 Day Readmission 197 (29.5)
(%)
Length of Stay
4.00 [3.00, 6.00]
(median [IQR])
1 Year Survival (%) 545 (81.6)
Discharge Home (%) 375 (56.1)

Negative
436
63 (14.4)

Positive
232
38 (16.4)

p

100 (22.9)

67 ( 28.9)

0.11

116 (26.6)

81 (34.9)

0.03

4.00 [3.00,
6.00]
367 ( 84.2)
268 ( 61.5)

4.00 [3.00,
7.00]
178 (76.7)
107 (46.1)

0.007

0.58

0.02
<0.001

Table 2. Adjusted Outcomes* Based on Cognitive Screening Result.
Unadjusted
Odds Ratio 95% CI
30-Day Readmission
60-Day Readmission
90-Day Readmission
1-year survival

1.16
1.33
1.46
0.62

0.75
0.92
1.02
0.42

1.80
1.92
2.08
0.92

Adjusted
Odds
Ratio
1.02
1.18
1.39
0.82

95% CI
0.64
0.79
0.94
0.53

1.64
1.75
2.06
1.27

*Adjusted for age, sex, race, admission source, Elixhauser score, Edmonton functional
independence score and Edmonton self-reported performance score.

DISCUSSION
• CI as detected by the Mini-Cog test was not associated with
readmission, length of stay, or 1-year mortality. However, it
was associated with the likelihood of discharge to nursing
home.
• Association between CI and post-hospitalization outcomes is
likely complex with many effect modifiers and confounders.
• Prior studies have focused on a specific population (e.g.
orthopedic surgery patients). We included all patients.
• Limitations: single center study; only English-speaking
patients were included; and the level of home support may
be a significant factor that is difficult to quantify.
• Other tools such as frailty assessment may be more useful in
predicting these specific outcomes in hospitalized older
adults.

FUNDING
Supported by National Center for Research Resources (NCRR), National Institutes of Health (NIH) through the
Clinical and Translational Science Awards Program (CTSA). Supported by the National Center for Advancing
Translational Sciences of the NIH.
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[1] Figure from “High blood pressure in older subjects with cognitive impairment” - Scientific Figure on ResearchGate.
Available from: https://www.researchgate.net/figure/Mini-Cog-Test-32-administration-and-scoring-1-Ask-the-patient-torepeat-3_fig1_304367970
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Walk a day in my shoes

Ryan Quarles, MD, Donald Kirton, MD, Reham
Shaaban, DO, Kevin Hinchey, MD,
Heather Z. Sankey, MD, MEd

NI VI Meeting #4 Tucson, AZ March 2019

INTRODUCTION: Background

METHODS: Interventions/Changes

Provider burnout has been identified as a public health crisis and
efforts to study and improve wellness are being undertaken by most
major academic medical centers. One of the strongest influences to
improve prevent provider burnout and improve wellness is
satisfaction at work and feeling appreciated. The relationships we
build at work can make or break our work environment and make a
significant difference between dreading work and enjoying it. When
a provider dreads the work that they do and the environment they
are in, then having empathy for our patients and coworkers is
affected.

Incoming residents in IM, Peds and OB/GYN were scheduled to
shadow floor nurses on their respective units.

Nursing role on the healthcare team

The shadowing sessions were developed to be 4 hours in length
with nurses who volunteered for the experience.

Appreciation of nursing clinical knowledge and skills

We believe we can improve empathy by building stronger
relationships within the healthcare team through a shared
understanding of our roles and how we can work better together
through shadowing experiences.

Aim/Purpose/Objectives
• Assess the short and long term impact on empathy,
understanding and communications of existing Nurse-Resident
shadowing experiences during orientation for our programs in
Internal Medicine (IM), Pediatrics (Peds) and Obstetrics And
Gynecology (OB/GYN).
• Expand the program to other residencies and programs to have
residents shadowing each other across specialties.
• Expand the shadowing experience to other healthcare
students and residencies and even wider into the system as
part of the system wide provider orientation.
• Develop a program by which nurses can shadow residents and
attendings to understand their workflow and structure.

After each session, residents and nurses involved were debriefed
with a pre-determined set of questions as well as open discussion
on observations , lessons learned and commitments with their
program leadership as well as a nurse manager.

RESULTS
22 incoming Internal Medicine and Med/Peds Residents shadowed
floor nurses for a period of 4 hours starting with a nurse to nurse
sign-out.
There were separate debriefings with each of the three groups
immediately after the experience that included both residents and
nurses
Residents in Ob/Gyn were scheduled for a four-hour shadowing
with volunteer nurses, but a misunderstanding by staff caused the
residents to shadow senior residents for 4 hours instead.

A semi-structured debriefing was recorded and transcribed for
review.
The transcribed debriefing is undergoing a qualitative analysis for
themes identified with the group.

• “We all have the same shared goal of doing best by our patients.”

• “Amazing how much they know”
• “Nurses are empowered to make some decision on their own”

Work load of nursing Staff

• “I learned the time differential between the time that the nurse spends with
the patient versus what the doctor spends with the patient. Doctor is in and
out and [the nurses] are always with [the patients]”
• “[Nurses] have to do a lot of charting. Lots of and lots of documentation”
• “Doctors have a way to get away, but nurses don’t. “

Source of learning

• “[The Nurse] knew everything about the patient, even about the patient’s
lives”
• “[Nurses] are a huge resource and wealth of information “

Communication

• “[Nurses] know a lot about the patient, you’d be at a huge disadvantage if
you do not reach out to your nurse and ask about what’s going on with the
patient.”

Safety

• “They have our (physicians) back”

Discussion: Barriers & Strategies
Barriers

Key Findings
METHODS: Measures/Metrics

RESULTS: Themes Identified

•Resident physicians are unaware of the level of involvement and
expertise nurses have in the care of their patients
• Experiencing the work flow and demands of a nurse’s day place
on the team creates deeper understanding and appreciation for
their role on the team.

•Recognition of the value of shadowing across the department.
•Building this experience into protected orientation time is very
important.

Next Steps and Sustainability

•Rework our structured debrief and debrief nurses and residents
separately
•Complete a pre-experience interview to understand pre-experience
knowledge
•Reassess practicality of surveying all residents on attitude

